Anxiety Disorders and Benzodiazepine Taper
At the end of the presentation, participants will be able to identify patients that would benefit from a benzodiazepine or “Z-drug” taper; review tapering strategies; and practice creating safe, unidirectional benzodiazepine or “Z-drug” tapers.
CE Credits: 1 hours (This activity is approved for 1.0 contact hour of continuing education by the American Association of Nurse Practitioners (which includes .75 hours of pharmacology).)
Please provide your contact information below to access the “Anxiety Disorders and Benzodiazepine Taper,” video.
Steven Elrod, PharmD, BCACP